Efficacy and ctDNA analysis in an updated cohort of patients with TRK fusion lung cancer treated with larotrectinib

被引：0

作者：

Hoejgaard, M. ^{[1
]}

Drilon, A. ^{[2
,3
]}

Lin, J. J. ^{[4
]}

Kummar, S. ^{[5
]}

Tan, D. S. W. ^{[6
]}

Patel, J. ^{[7
]}

Leyvraz, S. ^{[8
]}

Garcia, V. Moreno ^{[9
]}

Rosen, L. S. ^{[10
]}

Solomon, B. ^{[11
]}

Yachnin, J. ^{[12
]}

Liu, Y. ^{[13
,14
]}

Dai, M-S. ^{[15
]}

Norenberg, R. ^{[16
]}

Burcoveanu, D-I. ^{[17
]}

Yun, L. ^{[18
]}

Beckmann, G. ^{[19
]}

Mussi, C. E. ^{[20
]}

Shen, L. ^{[21
]}

机构：

[1] Rigshosp, Dept Oncol, Phase Unit 1, Copenhagen, Denmark

[2] Mem Sloan Kettering Canc Ctr, New York, NY USA

[3] Weill Cornell Med Coll, New York, NY USA

[4] MGH Massachusetts Gen Hosp, Thorac Oncol Dept, Boston, MA USA

[5] OHSU Knight Canc Inst, Div Hematol & Med Oncol, Ctr Hlth & Healing, Bldg 1 South Waterfront, Portland, OR USA

[6] NCCS Natl Canc Ctr Singapore, Med Oncol Dept, Singapore, Singapore

[7] Northwestern Univ, Dept Med, Chicago, IL USA

[8] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany

[9] Hosp Univ Fdn Jimenez Diaz, START Madrid FJD Early Phase Clin Trials Unit, Madrid, Spain

[10] UCLA, Hematol Oncol Santa Monica, Santa Monica, CA USA

[11] Avera Canc Inst, Div Hematol & Oncol, Sioux Falls, SD USA

[12] Karolinska Univ Hosp, Dept Oncol, Solna, Sweden

[13] Sichuan Univ, West China Hosp, Ctr Canc, Dept Thorac Oncol, Chengdu, Peoples R China

[14] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China

[15] Tri Serv Gen Hosp, Divis Oncol, Taipei, Taiwan

[16] Chrestos Concept GmbH & Co KG, Stat, Essen, Germany

[17] Bayer Healthcare Pharmaceut Inc, Med Affairs Oncol, Basel, Switzerland

[18] Bayer HealthCare Pharmaceut Inc, Mississauga, ON, Canada

[19] Bayer AG Pharmaceut, Res & Dev Pharmaceut, Berlin, Germany

[20] Bayer SpA, Div Pharmaceut, Milan, Italy

[21] Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Beijing, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

15MO

引用

页码：S48 / S49

页数：2

共 50 条

[41] LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TRK FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS
Perreault, Sebastien
Spano, Jean-Philippine
Nilsson, Anna
Deyell, Rebecca J.
Doz, Francois
Geoerger, Birgit
Gumus, Mahmut
Lassen, Ulrik N.
Nysom, Karsten
Valero-Arrese, Lorena
Idbaih, Ahmed
Bernard-Gauthier, Vadim
Neu, Natascha
Brega, Nicoletta
Drilon, Alexander
Laetsch, Theodore W.
van Tilburg, Cornelis M.
NEURO-ONCOLOGY, 2024, 26
[42] Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancer
McDermott, R.
van Tilburg, C. M.
Farago, A. F.
Kummar, S.
Tan, D. S. W.
Albert, C. M.
Berlin, J.
Lassen, U. N.
Doz, F.
Geoerger, B.
Mascarenhas, L.
Federman, N.
Reeves, J. A.
Dima, L.
Brega, N.
De La Cuesta, E.
Laetsch, T. W.
Hong, D. S.
Drilon, A.
ANNALS OF ONCOLOGY, 2020, 31 : S1101 - S1102
[43] Durability of response with larotrectinib in adult and pediatric patients with TRK fusion cancer
Hyman, D. M.
van Tilburg, C. M.
Albert, C. M.
Tan, D. S. W.
Geoerger, B.
Farago, A. F.
Laetsch, T. W.
Kummar, S.
Doz, F.
Lassen, U. N.
DuBois, S. G.
McDermott, R.
Mascarenhas, L.
Berlin, J. D.
Rudzinski, E. R.
Cox, M. C.
Nanda, S.
Childs, B. H.
Drilon, A.
Hong, D. S.
ANNALS OF ONCOLOGY, 2019, 30 : 162 - +
[44] Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
James C. H. Yang
Marcia S. Brose
Gilberto Castro
Edward S. Kim
Ulrik N. Lassen
Serge Leyvraz
Alberto Pappo
Fernando López-Ríos
John A. Reeves
Marc Fellous
Frédérique Penault-Llorca
Erin R. Rudzinski
Ghazaleh Tabatabai
Gilles Vassal
Alexander Drilon
Jonathan Trent
BMC Cancer, 22
[45] Durability of Response with Larotrectinib in Adult and Pediatric Patients with TRK Fusion Cancer
Leyvraz, Serge
Hyman, David M.
van Tilburg, Cornelis M.
Albert, Catherine M.
Tan, Daniel Sw.
Geoerger, Birgit
Farago, Anna F.
Laetsch, Theodore W.
Kummar, Shivaani
Doz, Francois
Lassen, Ulrik
Dubois, Steven G.
Mcdermott, Ray
Mascarenhas, Leo
Berlin, Jordan
Rudzinski, Erin R.
Cox, Michael C.
Nanda, Shivani
Childs, Barrett H.
Drilon, Alexander
Hong, David S.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 204 - 204
[46] Durability of response with larotrectinib in adult and pediatric patients with TRK fusion cancer
Hyman, D.
Tan, D. S. W.
van Tilburg, C.
Albert, C.
Geoerger, B.
Farago, A.
Laetsch, T.
Kummar, S.
Doz, F.
Lassen, U.
Dubois, S.
McDermott, R.
Mascarenhas, L.
Berlin, J.
Rudzinski, E.
Nanda, S.
Childs, B.
Drilon, A.
Hong, D. S.
ANNALS OF ONCOLOGY, 2019, 30
[47] Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma
Waguespack, Steven G.
Drilon, Alexander
Lin, Jessica J.
Brose, Marcia S.
McDermott, Ray
Almubarak, Mohammed
Bauman, Jessica
Casanova, Michela
Krishnamurthy, Anuradha
Kummar, Shivaani
Leyvraz, Serge
Oh, Do-Youn
Park, Keunchil
Sohal, Davendra
Sherman, Eric
Norenberg, Ricarda
Silvertown, Josh D.
Brega, Nicoletta
Hong, David S.
Cabanillas, Maria E.
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 186 (06) : 631 - 643
[48] Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer.
Hong, David S.
Shen, Lin
van Tilburg, Cornelis Martinus
Tan, Daniel Shao-Weng
Kummar, Shivaani
Lin, Jessica Jiyeong
Doz, Francois P.
McDermott, Raymond S.
Albert, Catherine M.
Berlin, Jordan
Bielack, Stefan S.
Lassen, Ulrik Niels
Tahara, Makoto
Norenberg, Ricarda
Shurshalina, Anna
Fellous, Marc Mardoche
Nogai, Hendrik
Xu, Rui-hua
Laetsch, Theodore Willis
Drilon, Alexander E.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[49] LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TRK FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS
Perreault, Sebastien
Doz, Francois
Deyell, Rebecca J.
Kebudi, Rejin
Nilsson, Anna
Nysom, Karsten
Geoerger, Birgit
Zhang, Yi-Zhuo
Bernard-Gauthier, Vadim
Neu, Natascha
de la Cuesta, Esther
Laetsch, Theodore W.
van Tilburg, Cornelis M.
NEURO-ONCOLOGY, 2024, 26
[50] Larotrectinib treatment of advanced TRK fusion thyroid cancer
Cabanillas, M. E.
Drilon, A.
Farago, A. F.
Brose, M. S.
McDermott, R.
Sohal, D.
Oh, D-Y.
Almubarak, M.
Bauman, J.
Chu, E.
Kummar, S.
Leyvraz, S.
Park, K.
Reeves, J. A.
Dima, L.
Maeda, P.
Rodrigues, L.
Brega, N.
Hong, D. S.
Waguespack, S. G.
ANNALS OF ONCOLOGY, 2020, 31 : S1086 - S1086

← 1 2 3 4 5 →